Neuregulin-1 modulates hippocampal gamma oscillations: Implications for schizophrenia

Cerebral Cortex

Volumn 19, Issue 3, 2009, Pages 612-618

  Fisahn, André ^a   Neddens, Jörg ^b   Yan, Leqin ^b   Buonanno, Andrés ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ErbB4; Hippocampus; Interneuron; Mouse; Parvalbumin; Rat

Indexed keywords

4 (3 BROMOANILINO) 6 (METHYLAMINO)PYRIDO[3,4 D]PYRIMIDINE; 4 AMINOBUTYRIC ACID; CARBACHOL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; KAINIC ACID; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR 1ALPHA; NEU DIFFERENTIATION FACTOR 1BETA; PARVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOREACTIVITY; INTERNEURON; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SCHIZOPHRENIA;

ANIMALS; BIOLOGICAL CLOCKS; ELECTROPHYSIOLOGY; HIPPOCAMPUS; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUREGULIN-1; PARVALBUMINS; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHIZOPHRENIA;

EID: 59749094475     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhn107     Document Type: Article

References (55)

1. Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, et al. 2004. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci. 7:1319-1328.
2. Bartos M, Vida I, Jonas P. 2007. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci. 8:45-56.
3. Bragin A, Jando G, Nadasdy Z, Hetke J, Wise K, Buzsaki G. 1995. Gamma (40-100 Hz) oscillation in the hippocampus of the behaving rat. J Neurosci. 15:47-60.
4. Brignola PS, Lackey K, Kadwell SH, Hoffman C, Horne E, Carter HL, Stuart JD, Blackburn K, Moyer MB, Alligood KJ, et al. 2002. Comparison of the biochemical and kinetic properties of the type 1 receptor tyrosine kinase intracellular domains. Demonstration of differential sensitivity to kinase inhibitors. J Biol Chem. 277:1576-1585.
5. Buonanno A, Fischbach GD. 2001. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol. 11:287-296.
6. Corfas G, Roy K, Buxbaum JD. 2004. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci. 7:575-580.
7. Csicsvari J, Jamieson B, Wise KD, Buzsaki G. 2003. Mechanisms of gamma oscillations in the hippocampus of the behaving rat. Neuron. 37:311-322.
8. Egeblad M, Mortensen OH, van Kempen LC, Jaattela M. 2001. BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells. Biochem Biophys Res Commun. 281:25-31.
9. Eilam R, Pinkas-Kramarski R, Ratzkin BJ, Segal M, Yarden Y. 1998. Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc Natl Acad Sci USA. 95:1888-1893.
10. Engel AK, Singer W. 2001. Temporal binding and the neural correlates of sensory awareness. Trends Cogn Sci. 5:16-25.
11. Fisahn A, Contractor A, Traub RD, Buhl EH, Heinemann SF, McBain CJ. 2004. Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations. J Neurosci. 24:9658-9668.
12. Fisahn A, Pike FG, Buhl EH, Paulsen O. 1998. Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature. 394:186-189.
13. Flames N, Long JE, Garratt AN, Fischer TM, Gassmann M, Birchmeier C, Lai C, Rubenstein JL, Marin O. 2004. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron. 44:251-261.
14. Ford JM, Krystal JH, Mathalon DH. 2007. Neural synchrony in schizophrenia: from networks to new treatments. Schizophr Bull. 33:848-852.
15. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, Rozov A, Whittington MA, Traub RD, Rawlins JN, et al. 2007. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron. 53:591-604.
16. Garcia RA, Vasudevan K, Buonanno A. 2000. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA. 97:3596-3601.
17. Gerecke KM, Wyss JM, Karavanova I, Buonanno A, Carroll SL. 2001. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J Comp Neurol. 433:86-100.
18. Gerlai R, Pisacane P, Erickson S. 2000. Heregulin, but not ErbB2 or ErbB3, heterozygous mutant mice exhibit hyperactivity in multiple behavioral tasks. Behav Brain Res. 109:219-227.
19. Green MF, Nuechterlein KH. 1999. Cortical oscillations and schizophrenia: timing is of the essence. Arch Gen Psychiatry. 56:1007-1008.
20. Gu Z, Jiang Q, Fu AK, Ip NY, Yan Z. 2005. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J Neurosci. 25:4974-4984.
21. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, et al. 2006. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 12:824-828.
22. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF. 2000. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci. 12:3239-3249.
23. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, et al. 2006. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci. 9:1477-1478.
24. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 10:40-68; image 45.
25. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, Sampson AR, Lewis DA. 2003. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 23:6315-6326.
26. Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS, Pelkey KA, Yang DJ, Xiong WC, Salter MW, et al. 2000. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron. 26:443-455.
27. Jinno S, Kosaka T. 2002. Patterns of expression of calcium binding proteins and neuronal nitric oxide synthase in different populations of hippocampal GABAergic neurons in mice. J Comp Neurol. 449:1-25.
28. Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG. 2004. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience. 126:591-598.
29. Kwon JS, O'Donnell BF, Wallenstein GV, Greene RW, Hirayasu Y, Nestor PG, Hasselmo ME, Potts GF, Shenton ME, McCarley RW. 1999. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Arch Gen Psychiatry. 56:1001-1005.
30. Kwon OB, Longart M, Vullhorst D, Hoffman DA, Buonanno A. 2005. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci. 25:9378-9383.
31. Lai C, Lemke G. 1991. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron. 6:691-704.
32. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6:312-324.
33. Li B, Woo RS, Mei L, Malinow R. 2007. The neuregulin-1 receptor ErbB4 controls glutamatergic synapse maturation and plasticity. Neuron. 54:583-597.
34. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet. 15:1995-2002.
35. Loeb JA, Hmadcha A, Fischbach GD, Land SJ, Zakarian VL. 2002. Neuregulin expression at neuromuscular synapses is modulated by synaptic activity and neurotrophic factors. J Neurosci. 22:2206-2214.
36. Longart M, Chatani-Hinze M, Gonzalez CM, Vullhorst D, Buonanno A. 2007. Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons. Brain Res Bull. 73:210-219.
37. Mann EO, Paulsen O. 2007. Role of GABAergic inhibition in hippocampal network oscillations. Trends Neurosci. 30:343-349.
38. Mann EO, Radcliffe CA, Paulsen O. 2005. Hippocampal gamma-frequency oscillations: from interneurones to pyramidal cells, and back. J Physiol. 562:55-63.
39. Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ, Preece AC, Dwyer S, Wilkinson JC, et al. 2006. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 141:96-101.
40. Ozaki M, Itoh K, Miyakawa Y, Kishida H, Hashikawa T. 2004. Protein processing and releases of neuregulin-1 are regulated in an activity-dependent manner. J Neurochem. 91:176-188.
41. Palhalmi J, Paulsen O, Freund TF, Hajos N. 2004. Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices. Neuropharmacology. 47:381-389.
42. Pinault D. 2008. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry. 63:730-735.
43. Reynolds GP, Beasley CL, Zhang ZJ. 2002. Understanding the neurotransmitter pathology of schizophrenia: selective deficits of subtypes of cortical GABAergic neurons. J Neural Transm. 109:881-889.
44. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. 2006. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet. 141:142-148.
45. Spencer KM, Nestor PG, Perlmutter R, Niznikiewicz MA, Klump MC, Frumin M, Shenton ME, McCarley RW. 2004. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA. 101:17288-17293.
46. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 71:877-892.
47. Stoll SW, Kansra S, Peshick S, Fry DW, Leopold WR, Wiesen JF, Sibilia M, Zhang T, Werb Z, Derynck R, et al. 2001. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplasia. 3:339-350.
48. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci USA. 100:8281-8286.
49. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. 2005. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry. 57:252-260.
50. Vreugdenhil M, Jefferys JG, Celio MR, Schwaller B. 2003. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol. 89:1414-1422.
51. Wilson TW, Hernandez OO, Asherin RM, Teale PD, Reite ML, Rojas DC. 2008. Cortical gamma generators suggest abnormal auditory circuitry in early-onset psychosis. Cereb Cortex. 18(2):371-378.
52. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, Weber J, Neiswender H, Dong XP, Wu J, Gassmann M, et al. 2007. Neuregulin-1 enhances depolarization-induced GABA release. Neuron. 54:599-610.
53. Wynn JK, Light GA, Breitmeyer B, Nuechterlein KH, Green MF. 2005. Event-related gamma activity in schizophrenia patients during a visual backward-masking task. Am J Psychiatry. 162:2330-2336.
54. Yau HJ, Wang HF, Lai C, Liu FC. 2003. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex. 13:252-264.
55. Zhang ZJ, Reynolds GP. 2002. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res. 55:1-10.